Psychiatry and Neurology, Neurology · Meriden, CT
NPI
1750327482
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
455 Lewis Ave Ste 202
Meriden, CT, 06451
Phone (203) 630-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
12,879 services
Medicare patients, 2024
209
Average age 71
Drug cost, 2024
$4.0M
6,724 prescriptions
Company payments, 2025
$11K
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hamid Sami was code J0588 (injection, incobotulinumtoxin a, 1 unit), 8,100 times for 16 patients. In total Hamid Sami billed 12,879 services in 37 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 8,100 | 16 | $3.91 | $32K |
| 99214 Office E&M - Established | Office | 459 | 188 | $81.47 | $37K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 208 | 19 | $5.15 | $1,071 |
| 96372 Injection Administration | Office | 47 | 14 | $10.36 | $487 |
| 95886 Electrical Nerve Conductivity | Office | 27 | 12 | $75.25 | $2,032 |
By year: 2022 $271K for 26,710 services; 2023 $161K for 14,112 services; 2024 $129K for 12,879 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hamid Sami prescribed most often to Medicare patients was Gabapentin, with 567 prescriptions and refills. In total Hamid Sami wrote 6,724 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 567 | 1,000 | 136 | $13K |
| Memantine Hcl Generic | 449 | 927 | 98 | $9,788 |
| Botox Onabotulinumtoxina | 305 | 824 | 95 | $442K |
| Oxycodone Hcl Generic | 246 | 246 | 18 | $2,936 |
| Lamotrigine Generic | 231 | 542 | 58 | $6,066 |
| Duloxetine Hcl Generic | 224 | 396 | 47 | $4,795 |
| Diazepam Generic | 197 | 225 | 34 | $859 |
| Levetiracetam Generic | 174 | 333 | 31 | $6,154 |
| Nurtec Odt Rimegepant Sulfate | 159 | 165 | 25 | $278K |
| Pregabalin Generic | 156 | 206 | 32 | $3,437 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 136 | 136 | 23 | $2,216 |
| Alprazolam Generic | 135 | 171 | 21 | $895 |
| Meloxicam Generic | 132 | 174 | 27 | $249 |
| Cyclobenzaprine Hcl Generic | 127 | 149 | 31 | $922 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 119 | 237 | 27 | $2,355 |
Brand drugs: 1,121 claims; generic drugs: 5,577 claims; opioid claims: 645.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hamid Sami $11K ($11K in general payments such as food, travel and fees) from 48 companies. The largest payer was Abbvie Inc. with $1,080.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 53 | $1,080 |
| EMD Serono, Inc. MRK.DE | 25 | $923 |
| Novartis Pharmaceuticals Corporation NVS | 27 | $711 |
| UCB, Inc. UCB.BR | 29 | $705 |
| Amgen Inc. AMGN | 15 | $687 |
| Pfizer Inc. PFE | 42 | $466 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $440 |
| Genzyme Corporation SNY | 5 | $415 |
| SK Life Science, Inc. | 10 | $354 |
| Axsome Therapeutics, Inc. AXSM | 12 | $352 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.